Pioglitazone Pharmacology episode artwork

EPISODE · Mar 21, 2019 · 12 MIN

Pioglitazone Pharmacology

from Real Life Pharmacology - Pharmacology Education for Health Care Professionals

On this episode, I cover pioglitazone pharmacology. The primary mechanism of action with pioglitazone is that it is an agonist at Peroxisome Proliferator Activated Receptor Gamma receptor. This improves insulin sensitivty in the periphery. Two common side effects exist with pioglitazone. This drug can cause weight gain and also contribute to edema. Pioglitazone has a boxed warning and is contraindicated in patients who have symptomatic heart failure. There are a few potential interactions with pioglitazone. Trimethoprim and gemfibrozil can inhibit the breakdown of pioglitazone. A couple of advantages of pioglitazone include that it is generic (inexpensive) and that it is dosed once daily. Be sure to check out our free Top 200 study guide – a 31 page PDF that is yours for FREE!

Episode metadata supplied by the publisher feed · Published Mar 21, 2019

Embed this episode

NOW PLAYING

Pioglitazone Pharmacology

0:00 12:06

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Real Life Pharmacology - Pharmacology Education for Health Care Professionals?

This episode is 12 minutes long.

When was this Real Life Pharmacology - Pharmacology Education for Health Care Professionals episode published?

This episode was published on March 21, 2019.

Can I download this Real Life Pharmacology - Pharmacology Education for Health Care Professionals episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!